FDA User Fee Reauthorization Signed Into Law

Prescription pill bottle, "Without federal employees,... Life would be frightening and dangerous. Your drinking water could be contaminated. You couldn't be sure grandma's medicine is safe." Federal Employees... They Work for U.S. www.theyworkforus.orgLast Friday, the Food and Drug Administration (FDA) Reauthorization Act of 2017 was signed into law, narrowly avoiding potential forced reduction in force (RIF) or furloughs for employees across the agency.

The newly signed bill, H.R. 2430, allows the FDA to collect industry user fees through 2022 to help pay for timely reviews of medical products, expedite the reviews of certain products, and to disclose its progress in meeting new goals.

Since its passage in 1992, the user fee laws and programs have helped hasten the drug and device review process, allowing patients access to new and innovative treatments without compromising the agency’s standards.